Kidney/Renal fibrosis, defined as an aberrant wound healing process in response to chronic injury, is characterized by the progressive and persistent accumulation of extracellular matrix components (ECM) in the kidney, ultimately leading to renal failure.
In 2018, the global Kidney/Renal Fibrosis Treatment market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Kidney/Renal Fibrosis Treatment status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Kidney/Renal Fibrosis Treatment development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.

The key players covered in this study
Galectin Therapeutics
Merck & Co.
F. Hoffman-La Roche Ltd.
Pfizer Inc.
InterMune Inc.
ProMetic Life-Sciences Inc.
La Jolla Pharmaceutical Company
Genzyme Corporation
BioLine Rx Ltd

Market segment by Type, the product can be split into
Angiotensin II Receptor Blockers (ARBs)
Angiotensin Converting Enzyme (ACE) Inhibitors
Pirfenidone
Renin Inhibitors
Vasopeptidase Inhibitors

Market segment by Application, split into
Commercial/Private Hospitals
Public Health Hospitals
Clinics
Home Treatment

Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Kidney/Renal Fibrosis Treatment status, future forecast, growth opportunity, key market and key players.
To present the Kidney/Renal Fibrosis Treatment development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Kidney/Renal Fibrosis Treatment are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.